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Abstract Relaxation exercises have become a standard
intervention for individuals with anxiety disorders but little
is known about their potential for anxiety relief during
pregnancy. The purpose of this study was to examine
psychoendocrine (i) baseline differences and (ii) changes
after a standardized relaxation period in pregnant women
with high versus low levels of anxiety. Thirty-nine third-
trimester high and low anxious pregnant women performed
active or passive relaxation while levels of anxiety, hypo-
thalamic–pituitary–adrenal (HPA) axis and sympathetic-
adrenal-medullary (SAM) system activity were assessed
before and after the relaxation period. In women with high
levels of trait anxiety, state anxiety (F(1,36) = 8.3,
p = .007) and negative affect (F(1,36) = 7.99, p = .008)
as well as ACTH (F(1,35) = 9.24, p = .002) remained
elevated over the entire course of the experimental proce-
dure, the last indicating increased HPA axis activity. In
addition, norepinephrine showed a constricted decrease of
relaxation reflecting lower response of the SAM-system
(F(1,37) = 4.41, p = .043). Although relaxation exercises
have become a standard intervention for individuals with
anxiety, pregnant women with high levels of trait anxiety
benefited less than women with low levels from a single
standardized relaxation period.
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Introduction
Research studying the effects of anxiety during pregnancy,
its impact on the course of pregnancy and peri/postnatal
mental health as well as its implications for treatment has
drawn increasing attention in the past decade. Prevalence
rates for the presence of any current anxiety disorder dur-
ing pregnancy lie between 6.6 and 21.7% (Andersson et al.,
2003; Borri et al., 2008; Heron, O’Connor, Evans, Golding,
& Glover, 2004). Most often, specific phobias, followed by
social phobias, panic disorders and generalized anxiety
disorders (GAD) are diagnosed (Borri et al., 2008; Ross &
McLean, 2006). Methodological differences such as
instruments used for the detection of disorders, the studied
samples or the use of low cut-off scores to define clinically
relevant anxiety account for rather high prevalence ranges.
Nevertheless, anxiety disorders are just as prevalent during
pregnancy as in non-pregnant women in their reproductive
years (Jacobi et al., 2004). While the clinical characteristics
are similar to those in pregnant and non-pregnant women,
pregnancy and the possible impact on obstetric and fetal
outcome constitutes a particular concern (Weisberg &
Paquette, 2002).
In a non-pregnant state, anxiety disorders have been
attributed to different neuroendocrine alterations—some of
them showing disorder specific patterns. More specifically,
dysregulation of noradrenergic neurotransmission has been
attributed to the development of anxiety disorders due to its
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effect on cortical and subcortical regions relevant for the
processing of fearful stimuli (Neumeister, Daher, &
Charney, 2005). This is reflected by increased activity of
the sympathetic-adrenal-medullary (SAM) system and
elevated levels of norepinephrine at baseline or reactive to
stress challenge in patients with posttraumatic stress dis-
order (PTSD) (Strawn & Geracioti, 2008), social phobia
(Aouizerate, Martin-Guehl, & Tignol, 2004), panic disor-
der (Esler et al., 2006) and GAD (Gorman, Hirschfeld, &
Ninan, 2002). The second major system involved in anxi-
ety is the hypothalamic–pituitary–adrenal (HPA) axis, and
there is evidence that abnormalities in HPA axis func-
tioning characterize a subset of anxiety disorders (Mathew,
Price, & Charney, 2008). Comparably, during pregnancy
altered neuroendocrine parameters in women with elevated
levels of anxiety have been reported by several authors;
some findings, however, revealed only modest associations
(Field & Diego, 2008; Field et al., 2003; Obel et al., 2005;
Sarkar, Bergman, Fisk, & Glover, 2006). While physio-
logical stress reactivity appears to be dampened during
pregnancy, this might be less the case in women with high
levels of stress and anxiety. Thus, in these women, over
maternal-placental pathways an excess in cortisol and/or
inadequate conversion of active cortisol to inactive corti-
sone may adversely impact fetal development (de Weerth
& Buitelaar, 2005). The known negative consequence of
anxiety during pregnancy on obstetric outcome, fetal and
child development among other factors has been attributed
to these alterations (Alder, Fink, Bitzer, Hosli, & Holzgreve,
2007; Federenko & Wadhwa, 2004; Schneid-Kofman,
Sheiner, & Levy, 2008; Talge, Neal, & Glover, 2007; Van
den Bergh, Mulder, Mennes, & Glover, 2005).
The management of anxiety disorders during pregnancy
is challenged by a lack of sound scientific data clarifying
efficacy as well as risk of pharmacotherapy and psycho-
therapy (e.g., confrontation therapy) (Misri & Kendrick,
2007; Vythilingum, 2008). Many women are reluctant to
take medications during pregnancy and prefer a psycho-
therapeutic approach. Additionally, the most potent con-
frontative interventions for the treatment of anxiety
syndromes have not been evaluated for their indication
during pregnancy. An alternative approach, which is
expected to have no harmful side effects is relaxation
training with medium to large effect sizes for the reduction
of anxiety in non-pregnant individuals (Manzoni, Pagnini,
Castelnuovo, & Molinari, 2008).
There are several studies that have investigated the
efficacy of relaxation exercises during pregnancy for dif-
ferent physical and psychological health problems. An
early study found relaxation beneficial to pregnant women
with elevated levels of blood pressure and a reduction of
systolic blood pressure (Little et al., 1984), a finding which
has been replicated in normotone patients suffering from
bronchial asthma (Nickel et al., 2006). Most but not all
studies report on a positive impact of relaxation exercises
on intrauterine growth retardation (IUGR), birth weight
and being small for gestational age, gestational length and
preterm delivery (Bastani, Hidarnia, Montgomery, Aguilar-
Vafaei, & Kazemnejad, 2006; Janke, 1999; Narendran,
Nagarathna, Narendran, Gunasheela, & Nagendra, 2005;
Omer, Friedlander, & Palti, 1986). Similarly, headache
improved after relaxation therapy in pregnant patients with
migraine or tension-type-headache (Marcus, Scharff, &
Turk, 1995). Psychologically, relaxation exercises and
mindfulness-based interventions have lowered levels of
anxiety and subjective reports of stress (Bastani, Hidarnia,
Kazemnejad, Vafaei, & Kashanian, 2005; Beddoe & Lee,
2008; Field et al., 1999; Teixeira, Martin, Prendiville, &
Glover, 2005; Vieten & Astin, 2008). Few studies have
evaluated the effect of relaxation exercises on physiologi-
cal parameters. Most consistently, a reduction in heart rate
has been reported (DiPietro, Costigan, Nelson, Gurewitsch,
& Laudenslager, 2008; Teixeira et al., 2005). On the other
hand, an increase in dopamine and a decrease in cortisol
and norepinephrine (DiPietro et al., 2008; Field, Diego,
Hernandez-Reif, Schanberg, & Kuhn, 2004; Field et al.,
1999; Teixeira et al., 2005) have been observed. Consid-
ering the adverse impact of an excessive maternal HPA-
activity on fetal development, it could be expected that the
physiological benefit of relaxation exercises contributes to
the improved pregnancy outcome as reviewed above.
The reported studies differ greatly with regard to the
relaxation technique applied, dependent variables and
study populations. Most important, none of them addressed
the question of whether pregnant women with enhanced
levels of anxiety psychologically and physiologically react
differently upon relaxation exercises. If however, relaxa-
tion techniques as an alternative to psychotropic medica-
tion are to be applied to women presenting with symptoms
of anxiety during pregnancy, more accurate insight into
their relaxation reactivity is essential.
In this paper, a second-order analysis from a randomized
controlled trial on the effectiveness of relaxation exercises
during pregnancy is presented with the following aims:
comparison of the psychoendocrine profile of pregnant
women with high and low levels of anxiety (i) at baseline
and (ii) in response to a standardized relaxation exercise.
Materials and Methods
Sample
The sample consisted of 39 healthy pregnant women which
were recruited at the obstetric outpatient department of a
university hospital. While waiting for a regular consultation,
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women were approached by a study collaborator, informed
about the study and given written informed consent if
interested in participation.
To be included, women had to be at least 18 years old,
German speaking and pregnant with a single, healthy fetus
between the 32nd–34th week of gestation. All women had
been informed of the healthy state of their fetuses with the
last ultrasound realized one to 2 weeks before study par-
ticipation. Exclusion criteria were intake of glucocorticoids
or other medication, severe fetal malformation and pre-
existing cardiovascular, nephrological, neurological or
metabolic diseases. For data analysis, women were allo-
cated to a high anxiety and low anxiety group according to
their State-Trait Anxiety Inventory (STAI) trait scores. For
a STAI-T cut-off score of 40, Grant et al., (Grant,
McMahon, & Austin, 2008) report a sensitivity of 80.95%
and a specificity of 79.75% for the presence of an anxiety
disorder. The authors propose to apply this score in order to
differentiate between women with high and low levels of
anxiety. Using this criterion, 28.2% (11) of the participants
were allocated to the high anxiety and 71.8% (28) to the
low anxiety group.
Sample characteristics are shown in Table 1. Groups did
not differ with regard to these variables. None of the
participants reported being on current treatment with
psychotropic medication. High anxious women differed
from low anxious women with regard to the number of
pregnancy consultations (14 vs. 10 consultations, p \ .05).
High and low anxious women did not differ with regard to
most of the pregnancy outcome parameters (gestational
age, birth weight, preterm birth, labor induction, analgesia
and complications during delivery), with the exception of
fetal distress during delivery, which tended to be more
frequent in high anxious women (v2 = 3.53, p = .06),
Study Design and Data Assessment
The study was designed as a randomized controlled trial
comparing progressive muscle relaxation (PMR), guided
imagery (GI) and passive relaxation (quiet resting) (PR)
with regard to psychophysiological reactivity. This sec-
ondary outcome analysis evaluated differences in high
anxious compared to low anxious women with regard to
psychoendocrine baseline characteristics and their response
to relaxation.
Women were invited to a 2 h visit at the hospital in the
afternoon and were instructed not to smoke, eat, drink coffee
or black tea, nor to do physical exercise 1 h prior to the
appointment. After arrival at the hospital they were asked to
go to the bathroom in order to ensure an undisturbed resting
period of 2 h. Each woman was then comfortably positioned
on the back in a semi-recumbent position followed by a
30-min resting period. Demographic information was
assessed and questionnaires on anxiety and positive and
negative affect were filled out. In addition, the study midwife
applied a permanent catheter for subsequent blood with-
drawals. One minute prior to relaxation, subjective levels of
relaxation as well as cardiovascular and endocrine measures
(pre) were assessed. This pre-testing period was followed by
a standardized 10-min period of one of the above mentioned
relaxation exercises. The previously recorded tracks were
given over headphones and the light in the room was slightly
dimmed. One (post1), ten (post10) and twenty (post20)
minutes after, subjective levels of relaxation, cardiovascular
and endocrine measures were assessed again. In addition,
patients re-evaluated their levels of anxiety and positive and
negative affect at 20 min after the procedure.
The research protocol was approved by the regional
ethics commission.
Measures
Psychological Measures
General demographic, health-related and pregnancy related
information (e.g., gestational week, pregnancy complica-
tions), as well as information on familiarity with relaxation
exercises, was collected during the accommodation period.
Two additional items assessed self-reported levels of stress
in private and occupational life on a five-point Likert-type
scale. In addition, the following two measures were used to
investigate anxiety and emotional state:
Spielberger State-Trait Anxiety Inventory. The German
version (Laux, Glanzmann, Schaffner, & Spielberger,
1981) of the STAI (Spielberger, 1983) was applied to
measure women’s general and situational level of anxiety.
Participants were allocated to a high and low anxiety group
Table 1 Sample characteristics (N = 39)
Mean (SD) % (n)
Age 33.4 (4.8)
Parity 0.5 (0.7)
Highest degree of education
Compulsory education 12.8% (5)
High school 7.7% (3)
Vocational school 20.5% (8)
Bachelor and master degree 59.0% (23)
Married or cohabiting 97.4% (38)
Nationality
Swiss or German 76.9% (30)
Other 23.1% (9)
Prepregnancy BMI 22.3 (4.4)
Prior experience with relaxation exercises 28.2% (11)
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according to their trait-anxiety scores. The STAI shows an
internal consistency range from .86 to .95 for the state
subscale and from .89 to .91 for the trait subscale.
Cronbach’s alpha was [.88 for state anxiety, and [.83 for
trait anxiety (Spielberger, 1983). The STAI has been
extensively used in experimental studies, including studies
with pregnant women (Bastani et al., 2005; Field et al.,
2003; Teixeira et al., 2005). For the detection of anxiety
disorders during pregnancy the Area under the Curve
(AUC) for the trait subscale is .89, indicating that this scale
correctly predicted diagnosis/non-diagnosis of antenatal
anxiety with a probability of 89.2% (Grant et al., 2008).
These authors therefore propose the use of a cut-off score of
[40 to identify pregnant women with a high probability of
meeting the diagnostic criteria of an anxiety disorder.
Positive and Negative Affect Schedule (PANAS, Watson,
Clark, & Tellegen, 1988). This scale consists of 10 items to
assess positive (PA) and 10 items to assess negative affect
(NA). Participants are asked to rate the affect items on a
scale from 1 to 5, based on the strength of emotion
(1 = ‘‘very slightly or not at all’’ and 5 = ‘‘extremely’’).
The scale has been shown to be highly internally consistent
and the two subscales are largely uncorrelated. Internal
consistency ranges from .86 to .90 for positive affect and
.84 to .87 for negative affect.
Before and after the relaxation exercise (pre-relaxation,
post-relaxation 1, post-relaxation 2, post-relaxation 3) partic-
ipants were asked to rate their experienced level of relaxation
on a visual analogue scale (VAS) consisting of a horizontal
line, 100 mm in length, ranging from ‘‘not at all relaxed’’ at
the left end to ‘‘extremely relaxed’’ at the right end. Partici-
pants marked on the line the point that represent their
perception of the current state. The VAS score could range
from 0 to 10 and was determined by measuring in centimeters
(with millimeter accuracy) the distance from the left hand end
of the line to the point that the participant marked.
Physiological Measures
Endocrine sampling methods and biochemical analyses.
Blood samples were collected at four time points (pre,
post1, post10, post20) using EDTA-monovettes with anti-
coagulant for plasma. Immediately after sampling, blood-
plasma samples were centrifuged at 3000 rotations/min for
10 min at 4C and stored in test tubes at -80 until anal-
ysis. For cortisol sampling, participants were asked to chew
on a bite-sized piece of paraffin wax to produce drooling
(Odusola, 1991). Saliva was then collected into 2 ml tubes
and stored at -20C until analysis.
The hormonal assays were conducted at the biochemical
laboratory of the University of Trier, Germany. For the quan-
titative determination of cortisol in saliva, a time-resolved
fluorescence immunoassay (TF-FIA) was performed. TF-FIA
showed excellent correlation with a commercially available
radioimmunoassay kit for salivary cortisol measurement
(Dressendorfer, Kirschbaum, Rohde, Stahl, & Strasburger,
1992). Variation coefficient for intra-assay variation ranged
between 4.0–6.7%, and 7.1–9.0% for inter-assay variation.
Recovery test scores ranged from 91 to 106%.
Adrenocorticotropin (ACTH) was determined using the
ACTH Immunoassay Kit (SG51041). It is a two-site
ELISA for the measurement of the biologically active 39
amino acid chain of ACTH and shows a cross reactivity of
-5.7% to low amounts (200 pg/ml) of added a-Melanot-
ropine. No further limitations of the specificity ([.01) are
reported. In recovery tests where known amounts of ACTH
were added to a previously assayed serum sample, the kit
detected on average 97% of the added ACTH. Controls
were run on every plate for determination of inter- and
intra-assay variability, which was \7% for this procedure.
Norepinephrine (NE) and epinephrine (E) in plasma
were assigned with the ClinRep Complete Kit (Cat.-Nr.:
1000), which is based on high performance liquid chro-
matography (HPLC) according to the method of Kringe,
Neidhardt and Lippmann (1982). Intra-assay variation is
expected to be around 8%.
Cardiovascular responses. Maternal cardiovascular
response was measured four times (pre-relaxation, post-
relaxation 1, post-relaxation 2, post-relaxation 3) with a GE
DINAMAP ProCare 400. It records systolic (SBP,
mmHg) and diastolic (DBP, mmHg) blood pressure as well
as heart rate (HR, bpm).
Pregnancy Outcome
Information on pregnancy outcome was extracted from
patient files after delivery. The following information was
used for the present analyses: gestational age, birth weight,
head circumference, umbilical cord pH values, intake of
medication during pregnancy (dichotomous), analgesics and
anesthesia during delivery (dichotomous), fetal distress
(dichotomous, defined as pH-value below 7.20, pathologic
cardiotocogram and meconium in the amniotic fluid) and
labor induction (dichotomous). In addition, number of
pregnancy consultations was assessed and number of preg-
nancy complications (diagnosis of preterm contractions,
hyperemesis, gestational diabetes, gestational hypertension
and proteinuria) was summarized to an obstetric complica-
tions sum score (OCSS).
Data Analysis
As the three experimental conditions did not differ with
regard to endocrine reactivity (Urech et al., 2010), the type
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of relaxation was not considered any further in the analysis.
After log-transformation, Cortisol, NE and E values met
the criteria for normal distribution. Baseline differences in
mean values of E, NE, cortisol and ACTH, cardiovascular
parameters and psychological variables (positive and neg-
ative affect, state anxiety and levels of stress in private and
occupational life) in patients with high versus low levels of
anxiety were investigated by Student’s t-tests.
To investigate pre-post group differences in psycho-
logical and endocrine variables, repeated measures analysis
of variance (ANOVA) with a twofold factor Group (high/
low anxiety) was calculated. For E and NE and the
psychological variables within-subject factor Time was
twofold (for hormones 1 min pre, 1 min post and for
psychological measures pre and 20 min post); while for
ACTH and cortisol the Time factor was fourfold with
additional measuring time points at 10 and 20 min post
relaxation. Greenhouse Geisser correction of degrees of
freedom was applied if assumption of sphericity was
violated. To test for between-subject effects the standard
setting of the quadratic sum type III was retained to
account for unequal group sizes. Effect sizes are reported
as partial Eta squared (gp
2).
All statistical analyses were conducted using SPSS
16.0.2 (SPSS Inc., Chicago, USA) and p-levels of \.05
were considered significant.
Results
Baseline Parameters in Women with High and Low
Levels of Anxiety
High anxious were compared to low anxious women with
regard to their baseline psychological and physiological
parameters. Table 2 displays mean values, standard devi-
ations and T-values for group comparison of mean values.
Anxious women reported higher levels of private stress
(T = 4.12, p \ .001), higher state anxiety scores (T = 2.9,
p \ .01) and more negative affect (T = 2.6, p \ .05). The
differences in levels of ACTH (T = 2.1, p \ .05) reflect an
increased baseline activity of the HPA-axis in highly
anxious compared to low anxious women. Interestingly,
only trait- but not state-anxiety scores were correlated with
enhanced HPA-activity at baseline.
Psychoendocrine Reactivity in Women with High
and Low Levels of Anxiety
To compare endocrine reactivity upon relaxation in high
anxious versus low anxious women, levels of epinephrine,
norepinephrine, cortisol, and ACTH were investigated over
the course of the experimental procedure. As the time
effect of the endocrine parameters did not vary between the
three different exercises, we did not additionally control for
relaxation technique. Figure 1 shows the course of the
hormones over time for the two groups. Levels of epi-
nephrine did not differ between groups and there was no
interaction of Time and Group. However, for norepineph-
rine a significant interaction effect between Time and
Group (F(1,37) = 4.41, p = .043, gp
2 = .107) and a time
effect (F(1,37) = 12.47, p = .001, gp
2 = .252) was
observed (see Fig. 1). This indicates that while both groups
did react with a decrease of norepinephrine levels, this was
significantly less pronounced for the group with high levels
of anxiety. For cortisol, only a time effect (F(2.08,
35) = 8.17, p = .001, gp
2 = .181) was observable while
groups did not differ. ACTH-levels did change over time
(F(1.28,33) = 4.23, p = .036, gp
2 = .108). In addition, a
significant group effect was found, with women in the high
anxiety group showing higher ACTH levels over the entire
course of the study (F(1,35) = 9.24, p = .002, gp
2 = .209).
For PANAS negative affect, a significant time
(F(1,36) = 8.16, p = .007, gp
2 = .185) and between-
subject effect (F(1,36) = 7.99, p = .008, gp
2 = .182) was
observed with women with high levels of anxiety reporting
more negative affect. However, the non-significant inter-
action effect shows that high and low anxious women did
not benefit differently from the relaxation period with
regard to their negative affect. The same applied to levels
of state anxiety in the STAI, where a highly significant
Table 2 Psychological and physiological baseline values in women
with high compared to low levels of anxiety
Variable High levels
of anxiety
Mean (SD)
Low levels
of anxiety
Mean (SD)
T-value
Private stress 3.3 (1.4) 1.8 (0.8) 4.12***
Occupational stress 2.3 (1.3) 2.3 (1.0) -0.03
STAI-state 38.9 (12.1) 31.2 (4.6) 2.9**
STAI-trait 48.5 (10.6) 30.2 (4.4) 7.7***
Positive affect 33.3 (4.7) 34.5 (5.8) -0.74
Negative affect 16.3 (6.9) 12.2 (2.9) 2.6*
Cortisol 7.9 (3.0) 7.3 (5.5) 0.97
ACTH 40.9 (26.5) 27.6 (12.8) 2.1*
E 38.5 (23.1) 34.6 (20.2) 0.24
NE 242.3 (136.4) 245.1 (83.6) -0.50
SBP 98.3 (10.3) 103.4 (14.9) -1.10
HR 83.1 (9.4) 78.7 (14.3) 0.93
ACTH adrenocorticotropin, E epinephrine, NE norepinephrine, SBP
systolic blood pressure, HR heart rate
* p \ .05, ** p \ .01, *** p \ .001
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time effect (F(1,36) = 12.88, p = .001, gp
2 = .264) and a
group effect (F(1,36) = 8.3, p = .007, gp
2 = .188) but no
interaction effect were observed.
With regard to self-rated levels of relaxation, VAS-scores
in both groups indicated higher levels of relaxation after
the relaxation procedure for all time points (post 1:
F(1,37) = 54.03, p = .000, gp
2 = .594); post 10: F(1,37) =
20.06, p = .000, gp
2 = .352; post 20: F(1,37) = 23.15,
p = .000, gp
2 = .385). A group effect was found for the VAS
scores prior to the relaxation lower scores in the high anxiety
group. However, no interaction effect was observed.
Psychologically, the relaxation procedure therefore
showed an effect from which high anxious women seemed
to benefit similarly to low anxious women.
Discussion and Conclusions
The present study’s aims were to assess the psychophysi-
ological baseline characteristics in women with high and
low levels of anxiety and to compare the endocrine reac-
tivity upon relaxation in these two groups. The results
suggest an increased activity of the HPA axis in pregnant
women with high levels of anxiety, with significantly
augmented levels of ACTH. Levels of cortisol were non-
significantly elevated. In addition to limited power due to
rather small sample size this may be the consequence of
higher context dependency of cortisol (nutrition, sleep
pattern, time of day). Baseline samples were extracted after
a waiting period of 30 min to account for these individual
differences; this may, however, also have washed out some
of the effects of the standardized relaxation procedure. On
the other hand, women may differ in their perception of the
catheterization as being painful and aversive which might
influence the baseline endocrine values. However, VAS
scores, which were used to assess level of pain after the
catheter was installed, displayed no association of pain
experience and endocrine baseline measures or level of
trait anxiety. The observed group differences in baseline
levels may therefore not be a result of differences in pain
experience.
Also, even though all of the measurements took place in
the afternoons there was still variability in time of about
3 h. Women were asked not to eat and drink 1 h before
their appointment but we did not standardize meals on the
experimental day and relied on self-reports.
Interestingly, in women with high levels of anxiety, the
HPA-hormones were not correlated while in women with
low levels of anxiety, ACTH and cortisol did significantly
correlate with each other. This is a finding which has pre-
viously been reported by Talley, Heitkemper, Chicz-Demet
and Sandman (2006) for pregnant women in abusive rela-
tionships. Comparably, ACTH and cortisol values in bat-
tered women did not correlate while they showed a clear
linear relationship in non-battered women. The authors
concluded that the experience of stress in this population
altered the relationship of HPA-axis hormones perhaps
resulting in an exhaustion of the adrenal glands incapable of
mounting a response to ACTH.
An alteration of HPA-activity has been reported also for
patients with anxiety disorders outside of pregnancy with
certain disorder specific patterns (Mathew et al., 2008). The
present study does not identify type of anxiety disorder nor
is the use of a STAI-trait cut-off score valid to make a
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diagnostic confirmation of the presence or absence of an
anxiety disorder. Nevertheless, as suggested by Grant et al.
(2008) the probability of a correct prediction of an anxiety
disorder/no anxiety disorder for the applied cut off score is
almost as high as 90%. Field et al. (2001) reported similar
findings for pregnant women with co-morbidly enhanced
levels of anxiety and depression. While they did not study
levels of ACTH, they found higher levels of cortisol and
dopamine. Comparable to our results, no baseline differ-
ences were found for epinephrine and norepinephrine. In
addition, for specific populations such as women awaiting
amniocentesis, where enhanced levels of state anxiety have
been observed, levels of cortisol were related to anxiety.
Again, these authors did not report on levels of ACTH
(Sarkar et al., 2006). Some authors found enhanced levels
of ACTH and/or cortisol in pregnant women with high
levels of stress (Obel et al., 2005; Sandman, Wadhwa,
Chicz-DeMet, Dunkel-Schetter, & Porto, 1997) or for
comorbid conditions (Evans, Myers, & Monk, 2008). The
present results therefore support the hypothesis of a change
in the HPA-axis anxiety-response threshold during preg-
nancy. Therefore, while pregnancy in general has been
associated with an improved stress ‘‘immune’’ state, it may
not apply to distressed and anxious women (de Weerth &
Buitelaar, 2005).
Most important, however, these differences were not
limited to baseline measurements but were also present
after a period of relaxation. One important scope of this
secondary outcome analysis was to determine the course of
endocrine patterns from baseline to 20 min after relaxation
in women with high compared to low levels of anxiety.
While comparable to others (Teixeira et al., 2005),
HPA-axis hormones did decrease over time, the noted
group differences in ACTH remained over the course of the
procedure. Therefore, women from the high anxiety group
did not benefit from the relaxation period by an additional
harmonization of the HPA-axis hormones. Also, the dif-
ferences between high and low anxious women were even
more crucial for norepinephrine: The significant interaction
effect indicates that levels of norepinephrine decreased in
women with high compared to those with low levels of
anxiety significantly less.
In addition, we did not observe an anxiety-specific
psychological benefit. While in both groups levels of state
anxiety and negative affect decreased from before to after
the intervention, there was no additional improvement in
women with high levels of anxiety.
Several explanations may relate to these observations.
The primary scope of the study was to pilot the use of
relaxation techniques and evaluate their psychobiological
actions. Even though the relaxation period was limited to a
10 min-period, this secondary analysis showed that women
with high levels of anxiety had less pronounced reactions
during these one-time exercises and they may need more
counselling, instructions and practice than low anxious
women. Also, it may be that high anxious women need
more time to relax and, thus, the 10 min period may have
been too short for these women to develop the same
psychological and physiological benefits as their low
anxious counterparts.
Future studies will therefore have to focus more differ-
entially on mid- to long-term effects of repeated relaxation
exercises during pregnancy on psychoendocrine parameters
in women with high levels of anxiety. Several authors have
found a psychological (Bastani et al., 2005; Field,
Hernandez-Reif, Diego, Schanberg, & Kuhn, 2005; Field
et al., 1999) and physiological (Field et al., 1999) benefit
from repeated relaxation; however they did not look for
separate effects in women suffering from anxiety. Espe-
cially since relaxation training is a standard intervention in
anxiety patients, it is of major importance to understand the
psychophysiological mechanisms in reducing symptoms of
anxiety during pregnancy.
Notably, the utility of relaxation training to positively
affect obstetric outcome is an additional field, which has
received only little attention in the scientific literature.
Anxiety during pregnancy has been associated with adverse
obstetric outcome (Alder et al., 2007), but few studies have
systematically evaluated the benefit of relaxation training
in these patient groups to improve obstetric variables.
While some authors have previously reported associations
between anxiety or mixed conditions and obstetric com-
plications (Andersson et al., 2003; Andersson, Sundstrom-
Poromaa, Wulff, Astrom, & Bixo, 2004; Kurki, Hiilesmaa,
Raitasalo, Mattila, & Ylikorkala, 2000), others have not
found such an association (Field et al., 2003). Further
research will, however, not only have to look for the
obstetric risks of highly anxious women but also under-
stand better the pathways by which anxiety contributes
to obstetric complications. Moreover, the psychophysiolog-
ical potency of regularly performed relaxation exercises to
improve obstetric outcome has yet to be elucidated
systematically.
Another limitation of this study which has to be
addressed further is a potential sample bias with the
majority of women being highly educated, in stable rela-
tionships and a comfortable socioeconomic situation and
therefore not representative of a general pregnant popula-
tion. Nevertheless, this is the first study to show that
women with high levels of anxiety do not respond as
sensitively to relaxation as low anxious women do, and this
needs to be considered when counselling women present-
ing with anxiety symptoms during pregnancy. If relaxation
exercises are to be imparted as part of a counselling
intervention, high anxious women should be monitored
carefully; issues and questions by patients should be
J Clin Psychol Med Settings (2011) 18:13–21 19
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rediscussed in the next consultation. Ideally, objective
measures (physiologic response) should complement
evaluation of subjective effectiveness.
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